Tradestie Institutional Equity Comparison Engine

VOR vs ELVN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ELVN Overall Edge

ELVN Captures Institutional Edge (3โ€“1 Pillars ยท 4โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Enliven Therapeutics, Inc. Common Stock (ELVN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while VOR counters with relative strength in Valuation. Fundamentally, VOR trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ELVN at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, VOR sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro) against ELVN sits in CONSOLIDATION (10th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner VOR
VOR N/M vs ELVN N/M Fwd P/E
Growth & Margin Winner ELVN
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner ELVN
1Y +94.6% vs +134.9% ยท 52W Pos 64% vs 69%
Options & Structure Winner ELVN
CONSOLIDATION (6th %ile IV) vs CONSOLIDATION (10th %ile IV)
VOR NASDAQ
Vor Biopharma Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$18.97
-2.32% 1D
Market Cap $1.2B
1M Return +5.21%
1Y Return +94.56%
Forward P/E N/M
Unified AI Score
57.8 / 100 HOLD
Tech 50.0 Fund 55.0 Flow 66.0 Mom 50.0
ELVN NASDAQ
Enliven Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$47.62
-2.42% 1D
Market Cap $3.6B
1M Return +27.6%
1Y Return +134.93%
Forward P/E N/M
Unified AI Score
36.2 / 100 SELL
Tech 15.0 Fund 44.0 Flow 68.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VOR +94.56% ELVN +134.93% Spread: +40.37 pp (ELVN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
VOR TTM Op. Margin: 0.0% ELVN TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VOR vs ELVN. Trailing 12-month operating profitability (VOR 0.0% vs ELVN 0.0%) and valuation multiples (VOR N/M vs ELVN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VOR (2) vs ELVN (4)
Institutional Metric VOR ELVN Criterion Row Winner
Market Capitalization Scale $1.2B $3.6B Larger Scale ELVN
Trailing P/E Ratio Valuation 0.1x N/M Lower Multiple VOR
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -125.4% -16.8% Higher ROE ELVN
52-Week Range Position Momentum 64% ($6โ€“$26) 69% ($15โ€“$62) Stronger Trend ELVN
Beta / 30D Volatility Risk Regime 1.90ฮฒ ยท 61% Vol 0.96ฮฒ ยท 59% Vol Lower Realized Risk ELVN
Unified Institutional Score Composite Signal 57.8 / 100 (HOLD) 36.2 / 100 (SELL) Higher Composite VOR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VOR vs ELVN Buy Guide
VOR CONSOLIDATION
52d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live VOR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ELVN CONSOLIDATION
59d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live ELVN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VOR nor ELVN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.